A major breakthrough in gene editing technology arose from integrating large language model AI with CRISPR experimental design, giving rise to CRISPR-GPT. This multiagent platform enables users of various expertise to design and analyze gene editing experiments more efficiently, democratizing access to complex molecular biology workflows. Complementing this, the first AI-designed gene editor, OpenCRISPR-1, was developed, showing improved activity and specificity compared to native proteins, heralding a new era of AI-driven biotherapeutics design.